GutMe!: IBS and Collagen Protein Powder an Interventional Study

In this study we would like to understand how or if a food-based supplement affects gut symptoms such as bloating, stomach cramps and irregular bowel habits. Through using a digital symptom tracking app for a few weeks, you may just learn more about exactly what is triggering your symptoms!

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Irritable Bowel Syndrome Colonic Diseases Colonic Diseases, Functional Digestive System Diseases Gastrointestinal Diseases Intestinal Diseases Irrit Irritable Bowel

Age range

18 year–100 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

ProofPilot (Virtual Study: https://p.proofpilot.com)

New York, 10003, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

US based
self report bloating

Exclusion criteria

vegan or vegetarian diet
suffering from any skin disorders
kidney disease
treated medical issues
glutamine sensitivity

Treatment and study plan

Collagen Protien Powder

Dietary Supplement

Collegen Protein Powser

Primary outcomes

Change in self-reported IBS symptoms

Time frame: Baseline, Week 4 and Week 10

Sponsors and collaborators

Lead sponsor

ProofPilot

Industry

Collaborators

Qina

Registry information

Acronym: GutMe

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Jan 28, 2020
Registry last updated: Feb 11, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed